Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
Applications | ELISA, FC, IF, WB |
Reactivities | Human, Mouse |
Anti-Laminin-2 LG5 [C3_Hu10], Human IgG1, kappa
Applications | ELISA, FC, IF, WB |
Reactivities | Human, Mouse |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Chikungunya virus human monoclonal antibody, clone E26D9
Applications | IF, Neutralize |
Reactivities | Human |
Jo-1 Antigen human polyclonal antibody, Purified
Applications | ELISA, ID |
Reactivities | Human |
Topoisomerase I (TOP1) human polyclonal antibody, Purified
Applications | ELISA, ID, WB |
Reactivities | Human |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
Applications | ELISA, FC |
Reactivities | Human |
Anti-NKp46 [Bab281], Human IgG1, kappa
Applications | FC, IF, IP |
Reactivities | Human, Macaque |
Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
TRIM21 human polyclonal antibody, Purified
Applications | ELISA, ID |
Reactivities | Human |
Recombinant Anti-Phl p 1 (Clone Clone 25)
Applications | Dot, ELISA, WB |
Reactivities | Rat |
Recombinant Anti-ED-B domain of fibronectin (Clone A2)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Recombinant Anti-ED-B domain of fibronectin (Clone G4)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | Bl, FC, IHC |
Reactivities | Human |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Recombinant Anti-TDRD3 (Clone RAB-C419)
Applications | ChIP, ELISA, IF |
Reactivities | Human |